| Nikola Nadia Roszko Augustynowicz, APRN | |
|
155 E Brush Hill Rd, Elmhurst, IL 60126-5658 | |
| (331) 221-1000 | |
| Not Available |
| Full Name | Nikola Nadia Roszko Augustynowicz |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Family |
| Location | 155 E Brush Hill Rd, Elmhurst, Illinois |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1104604255 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | 209.027572 (Illinois) | Primary |
| Entity Name | Edward Health Ventures |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1962452912 PECOS PAC ID: 4284531484 Enrollment ID: O20031216000616 |
News Archive
Astellas Pharma US, Inc., a subsidiary of Astellas Pharma Inc. based in Tokyo, Japan, announced today that the U.S. Food and Drug Administration (FDA) designated isavuconazole as a Qualified Infectious Disease Product (QIDP) for the treatment of invasive aspergillosis.
As cancer maintains its standing as the second leading cause of death in the U.S., researchers have continued their quest for safer and more effective treatments. Among the most promising advances has been the rise of nanomedicine, the application of tiny materials and devices whose sizes are measured in the billionths of a meter to detect, diagnose and treat disease.
Helsinn, the Swiss Group focused on building quality cancer care, announces today that its recently launched Helsinn Integrative Care division is meeting the cancer community at booth 6033 at the American Society of Clinical Oncology Annual Meeting, May 29-June 2, Chicago, Illinois.
Stimulating the brain with a weak electrical current is a safe and effective treatment for depression and could have other surprise benefits for the body and mind, a major Australian study of transcranial Direct Current Stimulation (tDCS) has found.
› Verified 5 days ago
| Entity Name | Elmhurst Memorial Healthcare |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457493454 PECOS PAC ID: 9638168602 Enrollment ID: O20040506001298 |
News Archive
Astellas Pharma US, Inc., a subsidiary of Astellas Pharma Inc. based in Tokyo, Japan, announced today that the U.S. Food and Drug Administration (FDA) designated isavuconazole as a Qualified Infectious Disease Product (QIDP) for the treatment of invasive aspergillosis.
As cancer maintains its standing as the second leading cause of death in the U.S., researchers have continued their quest for safer and more effective treatments. Among the most promising advances has been the rise of nanomedicine, the application of tiny materials and devices whose sizes are measured in the billionths of a meter to detect, diagnose and treat disease.
Helsinn, the Swiss Group focused on building quality cancer care, announces today that its recently launched Helsinn Integrative Care division is meeting the cancer community at booth 6033 at the American Society of Clinical Oncology Annual Meeting, May 29-June 2, Chicago, Illinois.
Stimulating the brain with a weak electrical current is a safe and effective treatment for depression and could have other surprise benefits for the body and mind, a major Australian study of transcranial Direct Current Stimulation (tDCS) has found.
› Verified 5 days ago
| Entity Name | Northshore University Healthsystem Faculty Practice Associates |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1497701882 PECOS PAC ID: 2163334699 Enrollment ID: O20040524000118 |
News Archive
Astellas Pharma US, Inc., a subsidiary of Astellas Pharma Inc. based in Tokyo, Japan, announced today that the U.S. Food and Drug Administration (FDA) designated isavuconazole as a Qualified Infectious Disease Product (QIDP) for the treatment of invasive aspergillosis.
As cancer maintains its standing as the second leading cause of death in the U.S., researchers have continued their quest for safer and more effective treatments. Among the most promising advances has been the rise of nanomedicine, the application of tiny materials and devices whose sizes are measured in the billionths of a meter to detect, diagnose and treat disease.
Helsinn, the Swiss Group focused on building quality cancer care, announces today that its recently launched Helsinn Integrative Care division is meeting the cancer community at booth 6033 at the American Society of Clinical Oncology Annual Meeting, May 29-June 2, Chicago, Illinois.
Stimulating the brain with a weak electrical current is a safe and effective treatment for depression and could have other surprise benefits for the body and mind, a major Australian study of transcranial Direct Current Stimulation (tDCS) has found.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Nikola Nadia Roszko Augustynowicz, APRN 1717 W Crystal Ln Unit 711, Mount Prospect, IL 60056-5458 Ph: (630) 347-0691 | Nikola Nadia Roszko Augustynowicz, APRN 155 E Brush Hill Rd, Elmhurst, IL 60126-5658 Ph: (331) 221-1000 |
News Archive
Astellas Pharma US, Inc., a subsidiary of Astellas Pharma Inc. based in Tokyo, Japan, announced today that the U.S. Food and Drug Administration (FDA) designated isavuconazole as a Qualified Infectious Disease Product (QIDP) for the treatment of invasive aspergillosis.
As cancer maintains its standing as the second leading cause of death in the U.S., researchers have continued their quest for safer and more effective treatments. Among the most promising advances has been the rise of nanomedicine, the application of tiny materials and devices whose sizes are measured in the billionths of a meter to detect, diagnose and treat disease.
Helsinn, the Swiss Group focused on building quality cancer care, announces today that its recently launched Helsinn Integrative Care division is meeting the cancer community at booth 6033 at the American Society of Clinical Oncology Annual Meeting, May 29-June 2, Chicago, Illinois.
Stimulating the brain with a weak electrical current is a safe and effective treatment for depression and could have other surprise benefits for the body and mind, a major Australian study of transcranial Direct Current Stimulation (tDCS) has found.
› Verified 5 days ago
Juliet Ibanez Panambo, AGPCNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: Po Box 745, Elmhurst, IL 60126 Phone: 630-400-1575 | |
Heather Ann San Juan, APN Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 613 S Poplar Ave, Elmhurst, IL 60126 Phone: 630-217-9620 | |
Kelly Rae Morris, DNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1200 S York St Ste 2000, Elmhurst, IL 60126 Phone: 331-221-9003 | |
Lina G Patel, APN Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 429 N York Rd, Elmhurst, IL 60126 Phone: 630-782-4050 Fax: 630-782-5021 | |
Judith G Benka, NP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1200 S York St Ste 2000, Elmhurst, IL 60126 Phone: 331-221-9002 Fax: 331-221-2747 | |
Erin C Daley, DNP, APRN, FNP-BC Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 155 E Brush Hill Rd, Elmhurst, IL 60126 Phone: 331-221-1000 | |
Izolda Rosario, AGNP-BC Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 501 W Lake St Ste 207, Elmhurst, IL 60126 Phone: 312-513-9863 |